AnGes Inc (AMGXF OTCGREY) stock market data APIs
$0.8002
0.44(122.2%)
as of February 3, 2025
AnGes Inc Financial Data Overview
AnGes, Inc. engages in the research and development of gene-based medical products. It develops HGF gene therapy product for the treatment of ischemic diseases; NF-"B Decoy Oligo DNA for chronic discogenic lumber back pain; and DNA vaccines for the treatment of hypertension and cervical intraepithelial neoplasia, as well as intranasal formulation of the COVID-19 vaccine. The company was formerly known as AnGes MG, Inc. and changed its name to AnGes, Inc. in July 2017. AnGes, Inc. was incorporated in 1999 and is headquartered in Ibaraki, Japan.
Prev. Close
0.3902
Open
0.8002
High
0.6302
Low
0.0102
52 wk Range
0.3353-0.5419
Market Cap
86 581 K
Shares Outstanding
240 M
Revenue
521 M
EPS
-27.39
Beta
0.685
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get AnGes Inc data using free add-ons & libraries
Get AnGes Inc Fundamental Data
AnGes Inc Fundamental data includes:
- Net Revenue: 521 M
- EBITDA: -6 538 749 952
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-02-09
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
AnGes Inc News
New
Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan
PALO ALTO, Calif. and OSAKA, Japan, May 10, 2022 /PRNewswire/ -- Eiger Biopharmaceuticals Inc. ("Eiger", Nasdaq: EIGR) and AnGes Inc. ("AnGes", TYO: 4563) today announced that the companies entered in...
Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccine
By Rocky Swift TOKYO, Aug 28 (Reuters) - Japan is making an aggressive move to grab enough coronavirus vaccine to inoculate its population four times over, a push the government hopes will instil con...
Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccine
By Rocky Swift TOKYO, Aug 28 (Reuters) - Japan is making an aggressive move to grab enough coronavirus vaccine to inoculate its population four times over, a push the government hopes will instil con...
Japan's AnGes speeds towards 2021 rollout in coronavirus 'vaccine war'
By Rocky Swift OSAKA, June 10 (Reuters) - Japanese biotech AnGes Inc expects its coronavirus vaccine to be ready as early as the first half of 2021, if it can overcome supply chain and production hur...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
